Giovanna Cutrona

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted Therapy.

To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted Therapy.

Journal: European journal of haematology

Published: March 22, 2026

Intraclonal Enrichment of IL-23 Receptor Complex Expression in the Proliferative Fraction of Chronic Lymphocytic Leukemia.

Intraclonal Enrichment of IL-23 Receptor Complex Expression in the Proliferative Fraction of Chronic Lymphocytic Leukemia.

Journal: International journal of molecular sciences

Published: December 30, 2025

Immunogenetic Architecture of Chronic Lymphocytic Leukemia at Early Stage: Insights from the O-CLL1 Cohort.

Immunogenetic Architecture of Chronic Lymphocytic Leukemia at Early Stage: Insights from the O-CLL1 Cohort.

Journal: Antibodies (Basel, Switzerland)

Published: December 08, 2025

Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia.

Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia.

Journal: International journal of molecular sciences

Published: April 29, 2025

MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.

MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.

Journal: Non-coding RNA

Published: July 25, 2024

Unraveling the Bone Tissue Microenvironment in Chronic Lymphocytic Leukemia.

Unraveling the Bone Tissue Microenvironment in Chronic Lymphocytic Leukemia.

Journal: Cancers

Published: September 14, 2023

Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates.

Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates.

Journal: Cancer immunology, immunotherapy : CII

Published: August 01, 2023

Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy.

Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy.

Journal: Frontiers in oncology

Published: April 02, 2023

The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia.

The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia.

Journal: American journal of hematology

Published: February 06, 2023

A High Percentage of CD16+ Monocytes Correlates with the Extent of Bone Erosion in Chronic Lymphocytic Leukemia Patients: The Impact of Leukemic B Cells in Monocyte Differentiation and Osteoclast Maturation.

A High Percentage of CD16+ Monocytes Correlates with the Extent of Bone Erosion in Chronic Lymphocytic Leukemia Patients: The Impact of Leukemic B Cells in Monocyte Differentiation and Osteoclast Maturation.

Journal: Cancers

Published: November 10, 2022

Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia.

Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia.

Journal: International journal of molecular sciences

Published: October 20, 2022

The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.

The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.

Journal: Hematological oncology

Published: April 05, 2022

Showing 1-12 of 79

Last Updated: 09/26/2026